Brad Canino
Stock Analyst at Guggenheim
(3.42)
Main Sectors:
Top Industries:
18 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CELC Celcuity | Initiates Coverage On: Buy | 110 | 50.51 | 117.78% | 1 | Sep 22, 2025 | |
ORIC ORIC Pharmaceuticals | Assumes: Buy | 18 | 11.56 | 55.71% | 1 | Sep 4, 2025 | |
RLAY Relay Therapeutics | Assumes: Buy | 15 | 5.48 | 173.72% | 1 | Sep 4, 2025 | |
NUVL Nuvalent | Assumes: Buy | 122 | 84.22 | 44.86% | 1 | Sep 4, 2025 | |
CCCC C4 Therapeutics | Initiates Coverage On: Buy | 8 | 2.27 | 252.42% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 24 | 200% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.89 | 105.66% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 21.43 | 86.65% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 2.57 | 94.55% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 450 | 8.28 | 5334.78% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 145 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 55 | 16.94 | 224.68% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 100 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 40.09 | -25.17% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 78 | n/a | n/a | 1 | Mar 31, 2021 |